Corporate Investor

Dongwha Pharmaceutical

Profile page for Dongwha Pharmaceutical

Dongwha Pharmaceutical

General information

Firm type

Corporate Investor

Year founded

AUM

Location

Region

Country

City

Seoul

Corporate office

Frequently asked questions

What is Dongwha Pharmaceutical?

Dongwha Pharmaceutical is a corporate investor headquartered in Seoul.

Where is Dongwha Pharmaceutical headquartered?

Dongwha Pharmaceutical is headquartered in Seoul.

What does Altss track for Dongwha Pharmaceutical?

Altss maintains an OSINT-verified profile of Dongwha Pharmaceutical covering investment focus (ESG policy, ticket size, target IRR, currency preference, regional focuses, industry focuses, technological focuses), team (service providers and advisors), deals (company deals and fund commitments), assets (real estate, public market positions, private companies, art and cultural holdings, philanthropy and foundations), and network (club memberships, associations, and event participation). Detailed values are available to Altss subscribers.

What type of firm is Dongwha Pharmaceutical?

Dongwha Pharmaceutical is classified by Altss as a Corporate Investor.

How does Altss source intelligence on Dongwha Pharmaceutical?

Altss combines OSINT (open-source intelligence) with regulatory filings, public disclosures, and licensed data partners. Source provenance is tracked to support compliance-ready research workflows.

How fresh is the Altss profile for Dongwha Pharmaceutical?

Dongwha Pharmaceutical's profile is part of Altss's continuous-refresh dataset, with a full update cycle at least every 30 days and priority changes applied as new information is verified.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on family offices?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classLive OSINT deal alerts
Start your free trial

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo